Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes

Detalhes bibliográficos
Autor(a) principal: Assis, Ápio Cláudio de Lima
Data de Publicação: 2013
Outros Autores: Gonçalves, Islania Giselia Albuquerque, Lima, Renata P. C., Almeida, Mônica M., Marinho, Alexsandro Fernandes, Barbosa Filho, José Maria, Cruz, Jader dos Santos, Vasconcelos, Darizy Flavia Silva Amorim de, Medeiros, Isac Almeida de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFBA
Texto Completo: http://www.repositorio.ufba.br/ri/handle/ri/12166
Resumo: Texto completo. Acesso restrito. p. 37-44
id UFBA-2_fe7e28f9e813672a1c1b762bf031c831
oai_identifier_str oai:repositorio.ufba.br:ri/12166
network_acronym_str UFBA-2
network_name_str Repositório Institucional da UFBA
repository_id_str 1932
spelling Assis, Ápio Cláudio de LimaGonçalves, Islania Giselia AlbuquerqueLima, Renata P. C.Almeida, Mônica M.Marinho, Alexsandro FernandesBarbosa Filho, José MariaCruz, Jader dos SantosVasconcelos, Darizy Flavia Silva Amorim deMedeiros, Isac Almeida deAssis, Ápio Cláudio de LimaGonçalves, Islania Giselia AlbuquerqueLima, Renata P. C.Almeida, Mônica M.Marinho, Alexsandro FernandesBarbosa Filho, José MariaCruz, Jader dos SantosVasconcelos, Darizy Flavia Silva Amorim deMedeiros, Isac Almeida de2013-07-11T13:29:29Z2013-07-11T13:29:29Z20130305-1870http://www.repositorio.ufba.br/ri/handle/ri/12166v. 40, n. 1Texto completo. Acesso restrito. p. 37-44The present study used functional and electrophysiological approaches to investigate the mechanisms by which warifteine, a bisbenzylisoquinoline alkaloid isolated from Cissampelos sympodialis Eichl., causes vasorelaxation of the rat thoracic aorta. 2. Warifteine (1 pmol/L–10 lmol/L) induced concentration- dependent relaxation (pD2 = 9.40 ± 0.06; n = 5) of endothelium-intact aortic rings precontracted with noradrenaline (10–100 lmol/L). The relaxation effects were not attenuated by removal of the endothelium. Warifteine also induced the relaxation of prostaglandin F2a (1–10 mmol/L)-precontracted rings (pD2 = 9.2 ± 0.2; n = 8). In contrast, the relaxant activity of warifteine was nearly abolished in high K+ (80 mmol/L)-precontracted aortic rings. In preparations incubated with 20 mmol/L KCl or with the K+ channel blockers tetraethylammonium (1, 3 and 5 mmol/L), iberiotoxin (20 nmol/L), 4-aminopyridine (1 mmol/L) or glibenclamide (10 lmol/L), the vasorelaxant activity of warifteine was markedly reduced. However, BaCl2 (1 mmol/L) had no effect on the relaxant effects of warifteine. 3. In vascular myocytes, warifteine (100 nmol/L) significantly increased whole-cell K+ currents (at 70 mV). Under nominally Ca2+-free conditions, warifteine did not reduce extracellular Ca2+-induced contractions in rings precontracted with high K+ or noradrenaline (100 lmol/L). 4. Together, the results of the present study indicate that warifteine induces potent concentration-dependent relaxation in the rat aorta via an endothelium-independent mechanism that involves the activation of K+ channels.Submitted by Santiago Fabio (fabio.ssantiago@hotmail.com) on 2013-07-08T15:11:55Z No. of bitstreams: 1 99999999999999999.pdf: 419451 bytes, checksum: bacc5f7b601e22fce4b4083185ff6439 (MD5)Approved for entry into archive by Rodrigo Meirelles(rodrigomei@ufba.br) on 2013-07-11T13:29:29Z (GMT) No. of bitstreams: 1 99999999999999999.pdf: 419451 bytes, checksum: bacc5f7b601e22fce4b4083185ff6439 (MD5)Made available in DSpace on 2013-07-11T13:29:29Z (GMT). No. of bitstreams: 1 99999999999999999.pdf: 419451 bytes, checksum: bacc5f7b601e22fce4b4083185ff6439 (MD5) Previous issue date: 2013SalvadorClinical and Experimental Pharmacology and Physiology10.1111/1440-1681.12029reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAbisbenzylisoquinoline alkaloidpotassium channelsrat aortavascular smooth muscle cellsvasodilatationwarifteineWarifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytesClinical and Experimental Pharmacology and Physiologyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleenginfo:eu-repo/semantics/openAccessORIGINAL99999999999999999.pdf99999999999999999.pdfapplication/pdf419451https://repositorio.ufba.br/bitstream/ri/12166/1/99999999999999999.pdfbacc5f7b601e22fce4b4083185ff6439MD51LICENSElicense.txtlicense.txttext/plain1762https://repositorio.ufba.br/bitstream/ri/12166/2/license.txt1b89a9a0548218172d7c829f87a0eab9MD52TEXT99999999999999999.pdf.txt99999999999999999.pdf.txtExtracted texttext/plain42696https://repositorio.ufba.br/bitstream/ri/12166/3/99999999999999999.pdf.txtd0a8e0f559d21d72472462fa484c1807MD53ri/121662022-08-08 13:17:34.135oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-08-08T16:17:34Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false
dc.title.pt_BR.fl_str_mv Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
dc.title.alternative.pt_BR.fl_str_mv Clinical and Experimental Pharmacology and Physiology
title Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
spellingShingle Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
Assis, Ápio Cláudio de Lima
bisbenzylisoquinoline alkaloid
potassium channels
rat aorta
vascular smooth muscle cells
vasodilatation
warifteine
title_short Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
title_full Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
title_fullStr Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
title_full_unstemmed Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
title_sort Warifteine, a bisbenzylisoquinoline alkaloid, induces relaxation by activating potassium channels in vascular myocytes
author Assis, Ápio Cláudio de Lima
author_facet Assis, Ápio Cláudio de Lima
Gonçalves, Islania Giselia Albuquerque
Lima, Renata P. C.
Almeida, Mônica M.
Marinho, Alexsandro Fernandes
Barbosa Filho, José Maria
Cruz, Jader dos Santos
Vasconcelos, Darizy Flavia Silva Amorim de
Medeiros, Isac Almeida de
author_role author
author2 Gonçalves, Islania Giselia Albuquerque
Lima, Renata P. C.
Almeida, Mônica M.
Marinho, Alexsandro Fernandes
Barbosa Filho, José Maria
Cruz, Jader dos Santos
Vasconcelos, Darizy Flavia Silva Amorim de
Medeiros, Isac Almeida de
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Assis, Ápio Cláudio de Lima
Gonçalves, Islania Giselia Albuquerque
Lima, Renata P. C.
Almeida, Mônica M.
Marinho, Alexsandro Fernandes
Barbosa Filho, José Maria
Cruz, Jader dos Santos
Vasconcelos, Darizy Flavia Silva Amorim de
Medeiros, Isac Almeida de
Assis, Ápio Cláudio de Lima
Gonçalves, Islania Giselia Albuquerque
Lima, Renata P. C.
Almeida, Mônica M.
Marinho, Alexsandro Fernandes
Barbosa Filho, José Maria
Cruz, Jader dos Santos
Vasconcelos, Darizy Flavia Silva Amorim de
Medeiros, Isac Almeida de
dc.subject.por.fl_str_mv bisbenzylisoquinoline alkaloid
potassium channels
rat aorta
vascular smooth muscle cells
vasodilatation
warifteine
topic bisbenzylisoquinoline alkaloid
potassium channels
rat aorta
vascular smooth muscle cells
vasodilatation
warifteine
description Texto completo. Acesso restrito. p. 37-44
publishDate 2013
dc.date.accessioned.fl_str_mv 2013-07-11T13:29:29Z
dc.date.available.fl_str_mv 2013-07-11T13:29:29Z
dc.date.issued.fl_str_mv 2013
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.repositorio.ufba.br/ri/handle/ri/12166
dc.identifier.issn.none.fl_str_mv 0305-1870
dc.identifier.number.pt_BR.fl_str_mv v. 40, n. 1
identifier_str_mv 0305-1870
v. 40, n. 1
url http://www.repositorio.ufba.br/ri/handle/ri/12166
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Clinical and Experimental Pharmacology and Physiology
publisher.none.fl_str_mv Clinical and Experimental Pharmacology and Physiology
dc.source.pt_BR.fl_str_mv 10.1111/1440-1681.12029
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFBA
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Repositório Institucional da UFBA
collection Repositório Institucional da UFBA
bitstream.url.fl_str_mv https://repositorio.ufba.br/bitstream/ri/12166/1/99999999999999999.pdf
https://repositorio.ufba.br/bitstream/ri/12166/2/license.txt
https://repositorio.ufba.br/bitstream/ri/12166/3/99999999999999999.pdf.txt
bitstream.checksum.fl_str_mv bacc5f7b601e22fce4b4083185ff6439
1b89a9a0548218172d7c829f87a0eab9
d0a8e0f559d21d72472462fa484c1807
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv
_version_ 1808459451183661056